NBIX
NEUROCRINE BIOSCIENCES INC
Latest Form 4:Sale$228KbyNorwalk Leslie V (Director) · filed Jul 30, 2026
NEUROCRINE BIOSCIENCES INC (NBIX) has 60 SEC Form 4 filings (174 transaction rows) in the rolling window, disclosed by 14 distinct insiders. Most recent filing: Aug 5, 2026.
The most active filer is Director Norwalk Leslie V with 5 filings. Insiders have net sold $62.4M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Kyle W. Gano
- Employees:1,800
- HQ:San Diego, CA, US
- IPO:1996-05-23
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$77.0M
reported sales (SEC code S)
Unique Insiders
14
in the rolling window
Market Cap
$15.7B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Sale | 1,250 | $228K | Jul 30 | SEC ↗ | |
| Chief Regulatory Officer | Sale | 4,367 | $791K | Jul 13 | SEC ↗ | |
| Chief Legal Officer | Sale | 10,000 | $1.8M | Jul 13 | SEC ↗ | |
| Chief Regulatory Officer | Sale | 3,401 | $607K | Jul 9 | SEC ↗ | |
| Chief Regulatory Officer | Sale | 2,737 | $489K | Jul 9 | SEC ↗ | |
| Chief Regulatory Officer | Sale | 8,433 | $1.5M | Jul 9 | SEC ↗ | |
Lippoldt DarinFirst in 7 months | Chief Legal Officer | Sale | 200 | $34K | Jun 30 | SEC ↗ |
Lippoldt DarinFirst in 7 months | Chief Legal Officer | Sale | 9,800 | $1.7M | Jun 30 | SEC ↗ |
SHERWIN STEPHEN AFirst filing | Director | Sale | 25,000 | $4.1M | Jun 9 | SEC ↗ |
| Director | Sale | 1,250 | $210K | Jun 8 | SEC ↗ | |
Cooke JulieFirst filing | Chief Human Resources Officer | Sale | 36,937 | $5.8M | Jun 4 | SEC ↗ |
Delaet IngridFirst filing | Chief Regulatory Officer | Sale | 2,261 | $354K | Jun 2 | SEC ↗ |
| Chief Scientific Officer | Sale | 11,000 | $1.8M | Jun 2 | SEC ↗ | |
Onyia JudeFirst filing | Chief Scientific Officer | Sale | 11,000 | $1.7M | May 29 | SEC ↗ |
Boyer David W.First filing | Chief Corp. Affairs Officer | Sale | 3,888 | $609K | May 28 | SEC ↗ |
GORMAN KEVIN CHARLESFirst filing | Director | Sale | 245,088 | $37.8M | May 21 | SEC ↗ |
POPS RICHARD FFirst filing | Director | Sale | 15,000 | $2.4M | May 18 | SEC ↗ |
Norwalk Leslie VFirst in 4 months | Director | Sale | 3,810 | $591K | May 14 | SEC ↗ |
| Chief Executive Officer | Sale | 36,400 | $4.8M | Jan 20 | SEC ↗ | |
| Director | Sale | 5,000 | $761K | Dec 17 | SEC ↗ | |
| Director | Sale | 1,190 | $185K | Dec 17 | SEC ↗ | |
Lippoldt DarinFirst filing | Chief Legal Officer | Sale | 4,376 | $699K | Dec 10 | SEC ↗ |
LYONS GARY AFirst filing | Director | Sale | 15,000 | $2.3M | Dec 4 | SEC ↗ |
BENEVICH ERICFirst filing | Chief Commercial Officer | Sale | 5,970 | $906K | Dec 2 | SEC ↗ |
MORROW GEORGE JFirst filing | Director | Sale | 15,000 | $2.2M | Nov 26 | SEC ↗ |
RASTETTER WILLIAM HFirst filing | Director | Sale | 18,000 | $2.7M | Nov 6 | SEC ↗ |
Gano KyleFirst filing | Chief Executive Officer | Sale | 300 | $43K | Nov 4 | SEC ↗ |
Related companies
NEUROCRINE BIOSCIENCES INC is in the Healthcare sector.